Skip to main content
Retour
Watch Compare

Zhengye Biotechnology Holding Ltd

Qualité des données : 100%
ZYBT
Nasdaq Manufacturing Chemicals
1,06 €
▲ 0,07 € (7,07%)
Cap. Boursière: 46,44 M
Prix
0,98 €
Cap. Boursière
46,44 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

ROE of 3,98% is below average
Debt/Equity of 0,30 — conservative balance sheet
Generating 3,76 M in free cash flow
Cash machine — converts 242,71% of earnings into free cash flow
Capital efficient — spends only 7,29% of revenue on capex
ROIC of 3,56% — low return on invested capital

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
3,98%
Au-dessus de la moyenne du secteur (-53,47%)
ROIC3,56%
Net Margin6,07%
Op. Margin8,82%

Sécurité

Debt / Equity
0,30
En dessous de la moyenne du secteur (0,30)
Current Ratio1,31
Interest Coverage4,06

Valorisation

PE (TTM)
29,96
Au-dessus de la moyenne du secteur (-1,48)
P/B Ratio1,19
EV/EBITDA10,02
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E 30,0 -1,5
P/B 1,2 1,6
ROE % 4,0 -53,5
Net Margin % 6,1 -41,5
Rev Growth 5Y % — 1,8
D/E 0,3 0,3

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Aucune estimation prévisionnelle disponible

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 25,53 M Net Income (TTM) 1,55 M
ROE 3,98% ROA 2,29%
Gross Margin 48,99% Operating Margin 8,82%
Net Margin 6,07% Free Cash Flow (TTM) 3,76 M
ROIC 3,56% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,30 Current Ratio 1,31
Interest Coverage 4,06 Asset Turnover 0,38
Working Capital 5,71 M Tangible Book Value 36,87 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 29,96 Forward P/E N/A
P/B Ratio 1,19 P/S Ratio 1,82
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 10,02 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 8,10%
Market Cap 46,44 M Enterprise Value 55,74 M
Per Share
EPS (Diluted TTM) 0,03 Revenue / Share 0,54
FCF / Share 0,08 OCF / Share 0,12
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 7,29% FCF Conversion 242,71%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024
Revenue 25,53 M
Net Income 1,55 M
EPS (Diluted) 0,03
Gross Profit 12,51 M
Operating Income 2,25 M
EBITDA —
R&D Expenses 1,75 M
SG&A Expenses —
D&A 3,31 M
Interest Expense 554 000,0
Income Tax 127 000,0

Balance Sheet

Annual, most recent first
Metric FY2024
Total Assets 67,58 M
Total Liabilities 19,28 M
Shareholders' Equity 38,90 M
Total Debt 11,84 M
Cash & Equivalents 2,55 M
Current Assets 24,33 M
Current Liabilities 18,62 M